8 -2 (30) 2020 — Adilova I.G., — TREATMENT APPROACH IN PATIENTS WITH CORONARY ARTERY DISEASE AND DIABETES MELLITUS

TREATMENT APPROACH IN PATIENTS WITH CORONARY ARTERY DISEASE AND DIABETES MELLITUS

Adilova I.G.,-Tashkent Institute of Postgraduate Medical Education, 100007 Uzbekistan Tashkent, Parkent 51 https://t.me/tashiuv.

Resume,

The current review article is devoted to foreign and our study to comparatively evaluate the end-point as the decline of the death rate after three various treatment approaches coronary bypass grafting+optimal conservative therapy, percutaneous coronary intervention+optimal conservative therapy, isolated optimal conservative therapy in both asymptomatic and symptomatic ischemic heart disease and diabetes mellitus patients.

Keywords: coronary heart disease, diabetes mellitus, percutaneous coronary intervention, coronary bypass grafting, optimal conservative therapy

First page

38

Last page

42

For citation: Adilova I.G., Treatment approach in patients with coronary artery disease and diabetes mellitus//New Day in Medicine 2(30)2020 38-42 https://cutt.ly/ZcQeANu

List of References

  1. Association AD. Diabetes Statistics. Accessed May 22, 2013.
  2. Cardiovascular disease and diabetes: The vulnerable patient. Eur Heart J Suppl 2012; 14 (suppl B):B4-B13.
  3. COURAGE Trial Research Group. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med. 2007; 356:1503-1516.
  4. Predicting cardiovascular events with coronary calcium scoring. N Engl J Med. 2008; 358:1394-1396.
  5. A randomized trial of therapies for type 2 diabetes and coronary artery disease. N Engl J Med.2009; 360:2503-2515.
  6. On-pump versus off-pump coronary artery bypass grafting in diabetic patients: a propensity score analysis. Ann Thorac Surg. 2004; 78:1604-1609.
  7. SYNTAX Investigators.Percutaneous coronary intervention versus coronary artery bypass grafting for severe coronary artery disease. N Engl J Med. 2009; 360:961-972.
  8. SYNTAX Investigators. Treatment of complex coronary artery disease in patients with diabetes: 5-year results comparing outcomes of bypass surgery and percutaneous coronary intervention in the SYNTAX trial. Eur J Cardiothorac Surg. 2013; 43:1006-1013.
  9. FREEDOM Trial Investigators. Strategies for multivessel revascularization in patients with diabetes. N Engl J Med. 2012; 367:2375-2384.
  10. Outcomes in patients with de novo left main disease treated with either percutaneous coronary intervention using paclitaxel-eluting stents or coronary artery bypass graft treatment in the Synergy between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery (SYNTAX) trial. Circulation. 2010; 121:2645- 2653.
  11. Everolimus-eluting stent versus bare-metal stent in ST-segment elevation myocardial infarction (EXAMINATION): 1 year results of a randomised controlled trial. Lancet. 2012; 380:1482-1490.
  12. Comparison of bypass surgery with drug-eluting stents for diabetic patients with multivessel disease. Int J Cardiol. 2007; 123:34-42.
  13. Cavelti-Weder C.,Babians-Brunner A. at all Effects of gevokizumab on glycemia and inflammatory markers in type 2 diabetes, Diabetes Care ,2012, vol.35 (pg.1654-1662)
  14. Comparison of coronary drug-eluting stents versus coronary artery bypass grafting in patients with diabetes mellitus. Am J Cardiol. 2007; 99:779-784.
  15. Drug-eluting stents vs. coronary artery bypass grafting in multivessel coronary disease. N Engl J Med. 2008; 358:331-341.
  16. Comparison of coronary artery bypass grafting with drug-eluting stent implantation for the treatment of multivessel coronary artery disease. Ann Thorac Surg. 2008; 85:65-70.
  17. ARTS-II Investigators. Multivessel coronary revascularization in patients with and without diabetes mellitus: 3-year follow-up of the ARTS-II (Arterial Revascularization Therapies Study­Part II) trial. J Am CollCardiol. 2008; 52:1957-1967.
  18. Long-term mortality of coronary artery bypass graft surgery and stenting with drug-eluting stents. Ann Thorac Surg. 2013; 95:1297- 1305.
  19. A multi-centrerandomised controlled trial of minimally invasive direct coronary bypass grafting versus percutaneous transluminal coronary angioplasty with stenting for proximal stenosis of the left anterior descending coronary artery. Health Technol Assess. 2004; 8:1-43.
  20. A meta-analysis of randomized control trials comparing minimally invasive direct coronary bypass grafting versus percutaneous coronary intervention for stenosis of the proximal left anterior descending artery. Eur J Cardiothorac Surg.2007; 31:691-697.

file

download